Age-specific characteristics of the basal insulin-rate for pediatric patients on CSII.
about
Basal insulin requirement of youth with type 1 diabetes differs according to age.Novopen Echo® for the delivery of insulin: a comparison of usability, functionality and preference among pediatric subjects, their parents, and health care professionalsPolymorphic basal rates of continuous subcutaneous insulin infusion among Taiwanese children with type 1 diabetes.Changes in Insulin Requirements From the Onset of Continuous Subcutaneous Insulin Infusion (CSII) Until Optimization of Glycemic Control.Insulin doses before and one year after pump start: children have a reversed dawn phenomenon.Predicting the optimal basal insulin infusion pattern in children and adolescents on insulin pumps.Insulin pump treatment in children and adolescents with type 1 diabetes: experiences of the German working group for insulin pump treatment in pediatric patients.Insulin delivery by injection in children and adolescents with diabetes.Continuous Subcutaneous Insulin Infusion in Children: A Pilot Study Validating a Protocol to Avoid Hypoglycemia at Initiation.Lower dose basal insulin infusion has positive effect on glycaemic control for children with type I diabetes on continuous subcutaneous insulin infusion therapy.Optimum bolus wizard settings in insulin pumps in children with Type 1 diabetes.Changes in basal insulin infusion rates with subcutaneous insulin infusion: time until a change in metabolic effect is induced in patients with type 1 diabetes.Mathematical modeling research to support the development of automated insulin-delivery systemsUpdate on mathematical modeling research to support the development of automated insulin delivery systems.Basal rate tests (24-hour fasts) performed in type-1 diabetic subjects with either absolute fasting or snacks containing negligible carbohydrate amounts result in similar glucose profiles: A randomized controlled prospective trial.Pharmacotherapy of type1 diabetes in children and adolescents: more than insulin?Basal Insulin Dose in Adults with Type 1 Diabetes Mellitus on Insulin Pumps in Real-Life Clinical Practice: A Single-Center Experience.Continuous Subcutaneous Insulin Infusion Characteristics in Type 1 Diabetes Children and Adolescents in Qatar
P2860
Q34407880-CCAD5DA5-07E2-4954-B243-1DD97CD91314Q34420016-B001191F-F8DA-4281-8DC4-B3B0815A9BEEQ35087418-6206F14E-B32E-4967-9B5D-66B95E464AF4Q35682701-E182D746-EAD3-4CD0-8D01-0AC6E698A994Q36229004-2FEDFE0B-35C2-471C-BD5E-A34A5DC0FF60Q36868130-FE2B0344-6B1A-4DDF-87F5-9649C9C76CC2Q37750270-19FA32EC-E0EC-4F95-BA9C-2CB82E79F58EQ37863741-B5AE9C86-B208-4073-8DFA-0AB6C161B90EQ38377046-7CF10B3F-D33D-44D3-BE0B-6077C51CFB40Q39994682-7C02A209-93E4-4209-9194-37C7ABD74C9FQ40101385-94104B81-7D9C-4B0D-B7B2-9823ADA8BD27Q42555641-8FE7D378-C090-4B40-B251-DBD7D31CA446Q42607729-CDCBF5A7-43B3-4060-BE4C-1885900BF63EQ42735600-B854D46C-23CB-4F04-A655-279B8C50A620Q48088947-DEB58286-33B9-4C83-B573-9923BB1C5978Q54943513-177B3460-AEDC-4852-A509-8FC76C0DBBE2Q55417315-E4505415-B5ED-4E97-B0F8-A00B5B11A3F4Q58736708-D2F6A336-3870-42BC-AC13-047C6C0C00BD
P2860
Age-specific characteristics of the basal insulin-rate for pediatric patients on CSII.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Age-specific characteristics of the basal insulin-rate for pediatric patients on CSII.
@en
Age-specific characteristics of the basal insulin-rate for pediatric patients on CSII.
@nl
type
label
Age-specific characteristics of the basal insulin-rate for pediatric patients on CSII.
@en
Age-specific characteristics of the basal insulin-rate for pediatric patients on CSII.
@nl
prefLabel
Age-specific characteristics of the basal insulin-rate for pediatric patients on CSII.
@en
Age-specific characteristics of the basal insulin-rate for pediatric patients on CSII.
@nl
P2093
P356
P1476
Age-specific characteristics of the basal insulin-rate for pediatric patients on CSII.
@en
P2093
B Heidtmann
C Klinkert
DPV-Initiative
P304
P356
10.1055/S-2007-990296
P577
2007-10-31T00:00:00Z